Management of HELLP Syndrome

Laboratory Findings and Diagnosis

The American College of Obstetricians and Gynecologists (ACOG) recommends that a platelet count below 100,000/mm³ indicates severe thrombocytopenia and active HELLP syndrome, with significant maternal risk 1, 2
The degree of thrombocytopenia correlates directly with the severity of liver dysfunction and predicts adverse maternal outcomes, according to the British Journal of Anaesthesia 3, 4
Platelet transfusion is mandatory before any surgical intervention when platelets are <50,000/mm³, and should be strongly considered at higher levels given the increased risk of abnormal coagulation and bleeding complications, as recommended by the British Journal of Anaesthesia 5, 1
Elevated liver enzymes, such as ALT and AST, frequently correlate with adverse maternal outcomes and indicate the need for urgent intervention, according to ACOG guidelines 1, 2
The Society for Maternal-Fetal Medicine (SMFM) recommends that AST, ALT, LDH, and total bilirubin are the most useful markers for following disease progression in HELLP syndrome 1, 2

Immediate Management

The American College of Obstetricians and Gynecologists (ACOG) recommends initiating magnesium sulfate immediately for seizure prevention in all women with HELLP syndrome and severe hypertension 1
Transfer to ICU or high-dependency unit for continuous monitoring of blood pressure, central venous pressure, urinary output, ECG, and oxygen saturation is recommended by ACOG 1, 2
Insertion of a urinary catheter for hourly output monitoring is recommended, with oliguria <400 mL/24h indicating severe disease, according to the British Journal of Anaesthesia 6, 7
Consideration of central venous catheter or pulmonary artery catheter for fluid management is recommended, as these patients are often relatively hypovolemic, according to the British Journal of Anaesthesia 5, 7

Delivery and Postpartum Care

Prompt delivery is recommended once maternal coagulopathy is corrected and severe hypertension controlled, according to ACOG guidelines 1, 2
Expect a high Caesarean section rate due to obstetric indications, as reported by the British Journal of Anaesthesia 3, 7
Laboratory monitoring should continue every 6-12 hours for at least 24-48 hours postpartum, as 30% of HELLP cases occur or worsen postpartum, according to ACOG guidelines 2

Critical Pitfalls to Avoid

Delaying delivery waiting for laboratory values to normalize is not recommended, as HELLP syndrome only resolves after delivery, and maternal mortality is 3.4% with delayed intervention, according to the British Journal of Anaesthesia 3, 4
Use of regional anesthesia (epidural/spinal) with platelets <100,000/mm³ is not recommended due to risk of epidural hematoma, according to the British Journal of Anaesthesia and ACOG guidelines 5, 1
Administration of corticosteroids to improve maternal HELLP outcomes is not recommended, as they are ineffective for maternal disease, according to SMFM guidelines 1

Hepatic Rupture in HELLP Syndrome

Pathophysiology and Clinical Presentation

Fibrin deposition within hepatic sinusoids causes sinusoidal obstruction and subsequent hepatic ischemia, leading to a predictable sequence of subcapsular hematomas, parenchymal hemorrhage, and hepatic rupture in patients with HELLP syndrome, according to the American College of Obstetricians and Gynecologists 8, 9, 10, 11
The underlying pathophysiology involves endothelial dysfunction with platelet aggregation, leading to microangiopathic changes that specifically target the liver in patients with pre-eclampsia and HELLP syndrome, as recommended by the Society for Maternal-Fetal Medicine 9, 10
65% of symptomatic HELLP patients present with right upper quadrant or epigastric pain, which should immediately trigger imaging to rule out subcapsular hematoma or hepatic rupture, as suggested by the American College of Radiology 8, 9, 11

Diagnostic Approach and Management

Abdominal imaging, such as ultrasound or CT, must be performed in suspected HELLP syndrome to rule out hepatic hemorrhage, infarct, or rupture, as recommended by the American College of Radiology 8, 9, 10, 11
Immediate maternal stabilization with blood pressure control and magnesium sulfate for seizure prophylaxis is necessary when hepatic rupture is identified or strongly suspected, according to the American College of Obstetricians and Gynecologists 8
Expeditious delivery after maternal stabilization, regardless of gestational age, is recommended for patients with HELLP syndrome complicated by hepatic rupture, as suggested by the Society for Maternal-Fetal Medicine 8, 9, 10

HELLP Syndrome Diagnosis and Management

Introduction to HELLP Syndrome

The American College of Obstetricians and Gynecologists acknowledges that the term "atypical HELLP syndrome" is not a standardized diagnostic category, but it typically refers to unusual presentations or timing of complete or partial HELLP syndrome, including postpartum presentation, early gestational age presentation, absence of hypertension, and absence of proteinuria despite meeting laboratory criteria 12

Clinical Presentation and Diagnosis

HELLP syndrome can occur in patients with normal blood pressure in 15% of cases, and the absence of proteinuria does not rule out the diagnosis 12
Atypical presentations of HELLP syndrome include asymptomatic presentation, absence of hypertension, and absence of proteinuria, which can occur in up to 15% of cases 12
Postpartum presentation of HELLP syndrome occurs in 30% of cases, with 20% occurring within 48 hours of delivery 12

Management and Treatment

The American College of Obstetricians and Gynecologists recommends immediate maternal stabilization with magnesium sulfate for seizure prophylaxis, abdominal imaging to rule out hepatic hemorrhage, infarct, or rupture, and prompt delivery after maternal stabilization if ≥34 weeks' gestation or if maternal/fetal condition deteriorates 12
The Society for Maternal-Fetal Medicine suggests that partial HELLP syndrome is a progressive condition that can rapidly deteriorate, and the presence of any two components of the triad warrants intensive monitoring and preparation for delivery 12

Timing of Delivery in HELLP Syndrome

Introduction to HELLP Syndrome Management

The American Association for the Study of Liver Diseases (AASLD) recommends that patients with HELLP syndrome should be delivered expeditiously after maternal stabilization, regardless of gestational age, as HELLP syndrome only resolves after delivery and delayed intervention carries a 3.4% maternal mortality risk 13, 14
The European Association for the Study of the Liver (EASL) and AASLD guidelines emphasize that the definitive treatment for HELLP syndrome is delivery after maternal stabilization 13, 14, 15

Immediate Delivery (Standard Management)

The AASLD recommends immediate delivery for HELLP syndrome diagnosed at ≥34 weeks gestation, requiring prompt delivery after maternal stabilization 13, 15
Immediate delivery is mandated for any gestational age with maternal deterioration (worsening laboratory values, severe symptoms, hepatic complications) 13, 15
The EASL guidelines recommend immediate delivery for any gestational age with fetal compromise (non-reassuring fetal status, intrauterine growth restriction with abnormal Doppler) 15
Hepatic hemorrhage, infarct, or rupture identified on imaging necessitates expeditious delivery after stabilization, according to the AASL guidelines 13, 14

Critical Pre-Delivery Stabilization Steps

Abdominal imaging (ultrasound or CT) should be performed to rule out hepatic hemorrhage, infarct, or rupture, as recommended by the AASLD guidelines 13, 14
The British Journal of Anaesthesia recommends administering fresh frozen plasma to correct coagulopathy as needed 16
Transfer to ICU or high-dependency unit for invasive monitoring with central venous and urinary catheters is recommended by the British Journal of Anaesthesia 16

Expectant Management (<34 Weeks)

The EASL guidelines suggest that when HELLP syndrome is diagnosed at very early gestational ages (<32-34 weeks), expectant management with close monitoring may be considered ONLY in the absence of severe symptoms, though this practice carries increased risk of adverse maternal outcomes 15
The EASL guidelines recommend strict criteria for expectant management, including gestational age <34 weeks with stable maternal condition (no worsening laboratory values, no severe symptoms) 15

Mode of Delivery

The British Journal of Anaesthesia notes that cesarean section rate is high (typically >70%) due to obstetric indications including unfavorable cervix, fetal distress, and maternal deterioration 16
General anesthesia may be required if platelets <100,000/mm³ preclude regional anesthesia, according to the British Journal of Anaesthesia 16

HELLP Syndrome as a Manifestation of Severe Preeclampsia

Definition and Classification

The American College of Cardiology and the American Heart Association recommend that HELLP syndrome should be considered a manifestation of severe preeclampsia rather than a distinct disorder, reducing confusion and ensuring clinicians recognize HELLP as part of the preeclampsia spectrum 17, 18, 19
Preeclampsia is defined as gestational hypertension (≥140/90 mmHg) developing at or after 20 weeks' gestation, accompanied by one or more new-onset conditions, including proteinuria, renal insufficiency, liver involvement, neurological complications, hematological complications, and uteroplacental dysfunction, with proteinuria present in approximately 75% of cases 18, 19
The American College of Obstetricians and Gynecologists recommends that HELLP syndrome represents a specific constellation of laboratory abnormalities, including hemolysis, elevated liver enzymes, and low platelets, which signifies a more serious part of the preeclampsia spectrum 17, 18, 19

Diagnostic Approach

The European Society of Cardiology recommends that new-onset hypertension with any organ dysfunction warrants complete laboratory workup, including LDH and platelet count, which are the two most important clinical tools for disease assessment 17, 18
The American College of Radiology recommends that abdominal ultrasound must be performed if symptoms suggest hepatic complications, including right upper quadrant pain, epigastric pain, or right shoulder pain, with a higher prevalence of hepatic hemorrhage or hematoma occurring with platelet count <20×10⁹/L 17, 20

Management Implications

The American Heart Association recommends that recognizing HELLP as severe preeclampsia ensures comprehensive evaluation, including seeking all other features of preeclampsia when HELLP is identified, with blood pressure control, seizure prophylaxis, and maternal organ dysfunction assessment being mandatory 18, 19
The Society for Maternal-Fetal Medicine recommends that prompt delivery is the only definitive treatment once maternal coagulopathy and severe hypertension are corrected, with delayed intervention carrying a 3.4% maternal mortality risk 17, 20

Clinical Manifestations of HELLP Syndrome

Neurological Signs of Severity

The European Society of Cardiology indicates that cefalea and alteraciones visuales are indicative of edema cerebral and predict complicaciones maternas adversas such as eclampsia in patients with HELLP syndrome 21
Hiperreflexia and clonus are signs of central nervous system compromise in patients with HELLP syndrome, as noted by the European Heart Journal 21
Convulsiones (eclampsia) occur in 52% of cases with HELLP and are significantly associated with cefalea, náuseas-vómitos, cambios visuales, and dolor epigástrico, according to the European Heart Journal 21
Ceguera del lóbulo occipital may present in severe cases of HELLP syndrome, as reported by the European Heart Journal 21

Complicaciones Hepáticas Críticas

The Journal of Hepatology recommends that hematoma subcapsular hepático or ruptura hepática should be suspected with persistent or worsening dolor in cuadrante superior derecho, especially with plaquetas <20×10⁹/L 22
Dolor in hombro derecho may indicate irritación diafragmática by sangrado hepático, as noted by the Journal of Hepatology 22
These complications require immediate abdominal imaging (ultrasonido or TC), according to the Journal of Hepatology 22